Indapamide SR Versus Candesartan and Amlodipine in Hypertension: The X-CELLENT Study | Zendy

G. London | Zendy; R. Schmieder | Zendy; Carlos Calvo | Zendy; Roland Asmar | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Indapamide SR Versus Candesartan and Amlodipine in Hypertension: The X-CELLENT Study

Author(s) -

G. London,

R. Schmieder,

Carlos Calvo,

Roland Asmar

Publication year - 2006

Publication title -

american journal of hypertension

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.009

H-Index - 136

eISSN - 1941-7225

pISSN - 0895-7061

DOI - 10.1016/j.amjhyper.2005.06.027

Subject(s) - indapamide , candesartan , amlodipine , medicine , blood pressure , ambulatory blood pressure , diastole , pulse pressure , placebo , systolic hypertension , cardiology , endocrinology , angiotensin ii , alternative medicine , pathology

Reducing systolic blood pressure (BP) is of major benefit to patients with isolated systolic hypertension, but lowering normal diastolic BP may be harmful in terms of cardiovascular risk. Effects of different drugs on systolic BP, diastolic BP, and pulse pressure are therefore of interest.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research